When an Infection Lingers: Understanding Post-Infectious Disease Syndrome

Table of Contents

• Key Points
• Background: Why This Research Matters
• What Are Post-Infectious Fatigue Syndromes?
• Major Outbreaks: A Historical Perspective
• The Controversy: Real Disease or Mass Hysteria?
• Evidence of a Physical Problem: Clues in the Brain and Muscles
• The Search for a Causative Agent
• How Could These Syndromes Develop?
• Clinical Implications: What This Means for Patients
• Study Limitations: What This Review Couldn't Prove
• Recommendations for Patients
• Frequently Asked Questions
• Source Information

Key Points

• Post-infectious disease syndrome involves prolonged fatigue, muscle weakness, and neurological symptoms after an infection.
• Evidence shows physical abnormalities in muscles, immune cells, and metabolism, supporting a biological basis for symptoms.
• Multiple viruses, including Coxsackie B, Epstein-Barr, hepatitis A, cytomegalovirus, and chickenpox, may trigger the syndrome.
• Recovery is often slow; in some outbreaks, over half of patients took over six months to return to full duties.
• Single blood tests for viral antibodies can be unreliable, so repeated or multiple tests may be needed.

Background: Why This Research Matters

When most people recover from an infection like a cold, the flu, or a stomach bug, they expect a brief period of tiredness before getting back to their normal lives. But a small but significant minority of patients recover from the acute symptoms of their illness only to be hit by a second wave of problems: a post-infectious syndrome. This paper, written by Dr. B.A. Bannister from the Royal Free Hospital's Department of Infectious Diseases at Coppetts Wood Hospital in London, reviews 50 years of research on this puzzling condition.

Not all post-infectious syndromes are caused by viruses. Two of the best-established examples are actually bacterial in origin:

• Rheumatic fever, first shown by Coburn in 1931 to follow infection with Streptococcus pyogenes (strep throat)
• Post-streptococcal glomerulonephritis (kidney inflammation), first defined by Ellis in 1942

The range of post-infectious disorders is remarkably broad. According to the review, known post-infectious complications include aplastic anemia (following non-A, non-B hepatitis), arthritis (following Shigella, salmonella, yersinia, campylobacter, meningococcus, rubella, or mumps), encephalitis (brain inflammation following measles, varicella, influenza, rubella, or certain vaccines), erythemas (skin rashes related to tuberculosis, leprosy, herpes simplex, and hepatitis B), glomerulonephritis, Guillain-Barré syndrome (following cytomegalovirus, Epstein-Barr virus, or hepatitis), autoimmune hemolysis, hemolytic uremic syndrome (following E. coli O157 infection), Reiter's syndrome, and serositis (inflammation of the membranes lining the chest and abdomen).

What Are Post-Infectious Fatigue Syndromes?

The specific syndrome at the center of this review is quite different from the well-accepted post-infectious conditions listed above. It consists of three core features: fatigue, muscle weakness, and variable neurological abnormalities. This syndrome has been reported both as sporadic (isolated) illness and in large outbreaks around the world.

Muscular Symptoms

The muscular symptoms are dominated by weakness, with or without pain. A hallmark feature described by patients is that weakness follows muscular effort and persists for several hours — or even several days — afterward. The leg muscles are most often affected, but the upper arms and back are also frequently involved.

Neurological Symptoms

The neurological symptoms are highly variable, but some complaints are almost universally present:

• Mental exhaustion and poor concentration (reported by nearly all patients)
• Tingling or burning sensations (paraesthesiae) in the limbs or face
• Localized weakness of a wrist, ankle, or the face
• Double vision (diplopia) and blurred vision
• Headaches
• Periods of excessive sweating and severe coldness of the limbs
• Altered hearing
• Frequent urination or retention of urine
• Emotional lability (mood swings)
• Vivid dreams

Despite the large number of symptoms described by sufferers, the physical signs found by doctors are often subtle and few. Fever is not a major sign, though many patients run a temperature of 37 to 37.5°C (98.6 to 99.5°F) throughout the day — a persistent low-grade fever.

Some physicians reported specific physical findings. Scott and the Royal Free Hospital physicians noted that lymphadenopathy (swollen lymph nodes) was common in their patients. The Royal Free doctors also reported facial weakness or paralysis in one-fifth of their cases, almost always on one side only. Many patients across different reports had mild nystagmus (involuntary eye movements). Doctors also found small areas of reduced sensation (hypoaesthesia) on the limbs and marked, often extremely localized, muscle tenderness. Transiently upgoing plantar responses (a reflex sign indicating possible nervous system involvement) were described by almost all authors, though they did not affect all patients; the Royal Free physicians found this sign in 20 percent of their cases. Muscle fasciculation (involuntary twitching) was also frequently observed, but doctors unanimously agreed on the complete absence of muscle wasting — a striking finding.

Major Outbreaks: A Historical Perspective

One of the most striking features of these fatigue syndromes is the occurrence of dramatic outbreaks, often affecting hospital staff. The table below summarizes the major outbreaks documented in the medical literature over a 50-year period:

• Los Angeles, 1934 — Hospital staff; approximately 200 cases
• Switzerland, 1937 and 1939 — Soldiers in a garrison; 130 and 75 cases respectively
• Iceland, 1948–49 — Akureyri district residents; hundreds of cases
• Adelaide, Australia, 1949–51 — Town residents; 700 cases
• New York State, 1950 — Local residents; 20 cases
• London, 1952 — Hospital staff; 14 cases
• Coventry, 1953 — Hospital staff; tens of cases
• London, 1955 — Hospital staff; 300 cases
• London, 1955–58 — Suburban residents; 53 cases
• Cumbria, 1955 — Rural adults and children; 230 cases
• Durban, South Africa, 1955 — Hospital staff; 100 cases
• London, 1964–66 — Suburban residents; 370 cases
• London, 1970–71 — Hospital staff; 150 cases
• Lake Tahoe, USA, 1984–85 — District residents; 90 cases

The long-term outcomes reported in these outbreaks are sobering. In the Durban outbreak, more than 10 percent of patients were still unwell after three years. In the Cumbria outbreak, 20 percent of patients had persistent or recurring symptoms for a number of years. In Iceland, only 44 percent of patients who were originally severely ill had fully recovered seven years after the outbreak. In Los Angeles, over half of affected staff took six months or more to return to full duties.

Some individual cases had specific, persistent neurological deficits. The review specifically mentions a young male doctor in the Cumbria outbreak, a nurse from the Middlesex Hospital in a London outbreak, and a nurse in the 1955 Durban outbreak who all developed marked foot-drop (inability to lift the front part of the foot) or ankle weakness that persisted for years.

The Controversy: Real Disease or Mass Hysteria?

Up until the 1960s, reports of these fatigue syndromes had apparently been received with little comment. But at the end of that decade, a group focused on psychological medicine began investigating episodes of "illness" in groups of schoolgirls, which they attributed to hyperventilation or "mass hysteria." They retrospectively examined the outbreaks reported from their own hospital (the Middlesex Hospital), the Royal Free Hospital, and several other outbreaks.

Their subsequent publications concluded that there was a strong element of hysteria in many of the outbreaks, and that the Royal Free Hospital outbreak was probably a "pseudo-epidemic" — a situation where patients with various vague symptoms were collected together and labeled as having an unusual disease, which then attracted other patients with vague complaints. They did acknowledge, however, that not all outbreaks could be considered purely hysterical.

Despite public rebuttals from several doctors who had originally reported the outbreaks, the "mass hysteria" theory became the majority view. To this day — and certainly as of the 1988 publication — few illnesses provoke such heated discussions between doctors, and such vehement responses to those complaining of these fatigue syndromes.

The author offers some counterarguments to the hysteria theory:

• Several reported outbreaks coincided with outbreaks of poliomyelitis, a much-feared disease at the time, yet patients and doctors quickly realized there was no rapid progression to paralysis and muscle wasting as would be typical in polio.
• Many other outbreaks had no association with polio at all, and the patients were ordinary community members rather than institutionalized populations.
• In community outbreaks, the sex ratio was usually near 1:1 (equal numbers of men and women), and young children were quite often affected — features not characteristic of "functional" or psychosomatic illness.

The result of this controversy was that fatigue syndromes became rather disreputable. The various names used — Iceland disease, Royal Free disease, epidemic neuromyasthenia, benign myalgic encephalomyelitis — were mentioned only disparagingly. Many doctors did not know what to think; others were plainly disbelieving.

Meanwhile, a very large number of people continued to present with complaints of prolonged fatigue on a sporadic basis. The public demand for answers was enormous: a review article in a national newspaper was said to have provoked enquiries from 11,000 individuals. The author's own infectious diseases unit received 20 to 50 enquiries per week requesting information or consultation, and colleagues at other units handled similar volumes. Many long-term fatigue sufferers subscribed to a support group called the ME (myalgic encephalomyelitis) Association.

Evidence of a Physical Problem: Clues in the Brain and Muscles

As scientific tools became more sophisticated, researchers began finding objective evidence that something physical was indeed wrong in these patients. This evidence came from multiple directions.

Brain Wave (EEG) Abnormalities

Early investigators studied the electroencephalogram (EEG), which records electrical activity in the brain, in patients who were particularly drowsy or disoriented. In the Cumbrian outbreak of 1955, a total of 23 cases were examined, of whom 15 had various non-specific abnormalities. A similarly abnormal picture was found in 43 patients from the London outbreaks of the 1950s.

Biochemical Evidence of Muscle Involvement

Even in early case reports, when the range of available tests was limited, biochemical evidence of muscle involvement was found. Poskanzer and colleagues demonstrated excessive creatinuria (excess creatine in the urine), with an increased creatine:creatinine ratio, suggesting damage or disuse of muscle. This returned to normal when the patient recovered.

Ramsay and Rundle carried out a detailed biochemical examination of ten patients and found:

• Increased serum myoglobin levels in eight patients, with levels falling during recovery from the initial weakness
• Depressed fasting blood pyruvate levels (a substance involved in energy metabolism)
• Normal creatine phosphokinase, lactate, and ATP levels
• Normal most transaminase and transpeptidase levels

This combination of findings suggested muscle damage associated with a disorder of oxidative metabolism — meaning the muscles' ability to use oxygen to produce energy was impaired. In a few patients, this was dramatically confirmed by ³¹P nuclear magnetic resonance (NMR) spectroscopy, a technique that measures phosphorus-containing molecules in tissues. In some patients, muscle fatigue and pain coincided with a failure to maintain adequate levels of creatine phosphate in the muscle cell, associated with a grossly excessive fall in pH (increased acidity). This suggests that oxidative phosphorylation (the process by which mitochondria produce energy) cannot keep up with muscle energy requirements. Normal pH and creatine phosphate levels may take many hours to be restored during rest, suggesting a severe defect in this metabolic pathway.

Unfortunately, although early studies were very promising, only a minority of patients tested have shown this evidence of "mitochondrial myopathy." The test is complex and not available to all patients.

Single-Fiber Electromyography Findings

A more encouraging abnormality was demonstrated using a technique called single-fiber electromyography (EMG), which studies a phenomenon called "jitter" in muscle fibers — a measure of how consistently nerve signals are transmitted to muscle fibers. Jamal and Hansen found significant abnormalities of these characteristics in 30 of 40 patients with fatigue syndromes. The nature of the abnormalities suggested the neuromuscular junction was intact (there was increased jitter without impulse blocking), and the authors concluded that conduction within the muscle fiber itself was abnormal. These abnormalities had already been described in patients with acute viral infections, so they are considered non-specific — but they do indicate that "something is wrong" in fatigued patients.

Muscle Biopsy Findings

As part of a larger study, Behan and colleagues carried out muscle biopsies on 20 fatigued patients. All of the patients had excess numbers of moderately enlarged type II muscle fibers, containing more mitochondria (the energy-producing structures of cells) than normal, as well as some tubular inclusion bodies. Fifteen of the 20 had necrosis (death) of single muscle fibers, without any inflammatory reaction, scattered throughout their biopsy samples. Similar changes within muscle fibers have been described in patients with neuropathy and inflammatory myopathy, and in patients with myalgia following acute, ill-defined illnesses. The findings are possibly not specific, but in one study they were associated with evidence of reduced respiratory function of the mitochondria.

The author concludes: "It seems undeniable that many, if not most, patients with fatigue syndromes will have a demonstrable abnormality of muscle physiology using the very discriminating tests now available." The importance of these findings is that they suggest a true pathological basis for the muscular fatigue that these patients describe.

The Search for a Causative Agent

Almost all patients with fatigue syndromes relate the beginning of their illness to a definite but mild viral-type illness. This observation has driven a long search for the responsible microorganism. Some initially promising findings were disappointingly unrepeatable in subsequent cases.

Enteroviruses: Coxsackie B and Related Viruses

One early report of recovery of ECHO 9 virus, or of rising titres of neutralizing antibody, may have represented just a local outbreak of mild viral meningitis rather than the fatigue syndrome itself. In 1970, Innes investigated four cases with symptoms of fatigue:

• The cerebrospinal fluid (CSF) of two patients produced viruses in cell culture — one Coxsackie B2 and one ECHO 3
• The other two patients had high titres of serum neutralizing antibodies to Coxsackie B2 and B5

Serological evidence suggesting exposure to Coxsackie B viruses has been found in some recent outbreaks:

• In an outbreak in Ayrshire, 18 of 22 patients studied had high titres of neutralizing antibodies to Coxsackie B. Twelve patients had titres of 1:512 or more, compared with only 4 percent of the general population having similarly high titres.
• In a further outbreak, 20 patients were compared with 100 normal controls and again had higher titres of neutralizing antibody.
• Another uncontrolled study in West Kilbride showed very similar results.
• Similarly raised titres of neutralizing antibody were found in the study by Behan and colleagues, and six of their patients had IgM antibodies to Coxsackie B (IgM antibodies indicating recent or ongoing infection).

These findings are interesting, the author notes, even though only one of the studies used concurrently tested controls. Importantly, there is no evidence of rising or falling titres of neutralizing antibody to Coxsackie B; all of the titres that were repeated showed static levels. This is perhaps not surprising: the initiating illness is seldom severe enough to drive the patient to seek medical advice, and it is often several weeks before persisting fatigue brings them to the doctor. By that time, the window for detecting antibody changes — and for isolating the virus itself — has usually passed.

Coxsackie virus would be a strong candidate for causing a disease affecting both the nervous system and the muscles. It is already known to cause meningitis, meningoencephalitis, pericarditis, cardiomyopathy, and Bornholm disease (a painful viral infection of the chest muscles). Coxsackie B RNA sequences have been detected in cardiac muscle biopsies from patients with cardiomyopathies.

Indirect support for the enterovirus theory (the family that includes ECHO, Coxsackie, and polio viruses) comes from the findings of Sigurdsson and colleagues: prior exposure to an outbreak of fatigue syndrome in Iceland modified patients' response to subsequent polio immunization.

Epstein-Barr Virus: Another Suspect

Coxsackie and related enteroviruses are not the only candidates. The Epstein-Barr virus (EBV), the cause of infectious mononucleosis (glandular fever), has also enjoyed supporting evidence. It has long been known that infectious mononucleosis may be followed by a prolonged period of malaise and fatigue. In 1982, Tobi and colleagues described evidence suggesting that excess levels of IgM antibodies against the EBV capsid antigen (CA) persisted in their patients.

To understand this, it helps to know how the immune system typically responds to EBV. The first serological response is the appearance of antibodies to a small range of early antigens (EA), followed by IgM anti-EBVCA. During convalescence, IgM anti-EBVCA is replaced by IgG anti-EBVCA, and finally antibodies to EBV nuclear antigen (EBNA) appear. Two papers from 1985 described fatigued patients with IgG anti-EBVCA and anti-EBNA, but without IgM anti-EBVCA, who nevertheless had persisting EA antibodies. This was taken as firm evidence of an abnormal persistence of EBV activity in these patients.

However, when local epidemiologists, in association with the Centers for Disease Control (CDC) in Atlanta, investigated cases and controls from the outbreak, the picture became more complicated. They studied the serology of 15 cases compared with age-, sex-, and race-matched controls and found that, although the cases were more likely to have increased anti-EA and IgG anti-VCA titres, they were equally more likely to have raised IgG antibody levels to cytomegalovirus and herpes simplex virus. Moreover, on repeated testing, fourfold differences in titres were obtained from the same serum sample on nearly 18 percent of occasions. This highlights the pitfalls of diagnosing persisting infections by testing single, uncontrolled serum samples.

Other Potential Triggers

Coxsackie B and EBV are not the only contenders. Fatigue is known to follow:

• Hepatitis A (whose virus, like an enterovirus, is transmitted via the gut)
• Cytomegalovirus infection
• A variety of severe viral illnesses
• Chickenpox — the patient with the severe muscle oxidative defect mentioned earlier was well until he had chickenpox

Influenza viruses, measles, and other paramyxoviruses are known to infect human peripheral blood lymphocytes (white blood cells), altering some of their specialized functions. Novel viruses were also being considered at the time of writing: the proposed SMON virus, and the newly discovered HBLV (human B-lymphotropic virus), which was "looking" for an acute primary disease to explain its presence in human lymphocytes.

The author draws an important conclusion: "The likely truth is that more than one aetiological agent can be associated with post-viral fatigue." It is even possible that the close association in time of two related infections could modulate the patient's long-term response. For example, dengue hemorrhagic fever is the effect of consecutive exposures to different dengue virus types. Could the experience with polio immunization in Iceland represent similar behavior of enteroviruses? The question of aetiology, the author states, must remain open while the natural variation of human responses to viral infections is further studied.

How Could These Syndromes Develop?

The pathogenesis (mechanism of disease development) of post-infectious conditions is a complex subject. The main categories of immune mechanisms discussed in this context include:

1. Molecular mimicry and autoimmunity — where antibodies produced against a virus mistakenly attack the body's own tissues. This is an attractive explanation for selective tissue damage after infection. For example, antibodies with an affinity for cardiac muscle may play a part in the pathogenesis of rheumatic fever, and the appearance of anti-I cold haemagglutinins (antibodies that attack red blood cells at cold temperatures) after certain infections.
2. Immune complex disorders — where antibodies and viral antigens clump together and deposit in tissues, causing damage.
3. Lymphocyte function and dysfunction — where the white blood cells that coordinate the immune response behave abnormally.
4. The role of allergy
5. The role of host susceptibility — why do some people get sick while others don't?

Methods and facilities for studying these factors were limited at the time of writing, but were diversifying in both number and sophistication.

Immune Cell Abnormalities Found

Emerging results from immune studies showed some differences between patients and healthy controls. The review describes a study comparing 11 "acute" cases (recently affected) and 29 "chronic" cases (long-term sufferers) with healthy controls:

• The acute cases had significantly reduced T8 counts (a type of suppressor/cytotoxic T cell)
• The chronic cases had reduced T4 counts (helper T cells)
• The chronic group had significantly lowered T4:T8 ratios — an important measure of immune balance

Hamblin and colleagues studied 17 patients who had been fatigued for between one and 10 years following infectious mononucleosis. They showed a reduced T4:T8 ratio in cases compared with healthy controls, which returned to normal in the ten patients who recovered. This recovery of immune parameters alongside clinical improvement is a particularly compelling piece of evidence, suggesting the immune changes are directly linked to the disease process rather than being incidental findings.

Clinical Implications: What This Means for Patients

For patients suffering from prolonged fatigue after an infection, this review offers several important messages:

The Symptoms Are Real

Perhaps the most important message is that the symptoms are not "all in the head." The review presents substantial evidence that many patients with post-infectious fatigue syndromes have objective abnormalities — in muscle biochemistry, in muscle structure on biopsy, in nerve-to-muscle signaling, and in immune cell populations. As the author states, "It seems undeniable that many, if not most, patients with fatigue syndromes will have a demonstrable abnormality of muscle physiology using the very discriminating tests now available."

Multiple Infections Can Trigger the Syndrome

Patients should understand that there is no single "fatigue virus." Evidence points to enteroviruses (especially Coxsackie B), Epstein-Barr virus, hepatitis A, cytomegalovirus, chickenpox, and potentially other agents. This means a prior diagnosis of any of these infections does not rule out post-infectious fatigue as a possible explanation for ongoing symptoms.

Recovery Can Be Slow — But It Happens

Recovery times vary enormously. Historical outbreak data show that over half of affected hospital staff in Los Angeles took six months or more to return to full duties. The Durban outbreak saw over 10 percent still unwell after three years. In Iceland, only 44 percent of severely affected patients had fully recovered seven years later — but this also means that a substantial proportion did recover, and in Hamblin's EBV study, 10 of 17 patients recovered with normalization of their immune parameters. The prognosis is not hopeless, even if recovery can be slow.

The Scale of the Problem

The public health burden is significant. A single newspaper article provoked 11,000 enquiries, and the author's own unit received 20 to 50 enquiries per week. This is not a rare or isolated problem — it affects large numbers of people across many countries.

Study Limitations: What This Review Couldn't Prove

This review has several important limitations, which the author acknowledges directly:

• Methodological weaknesses in the underlying studies: Only one of the Coxsackie B antibody studies used concurrently tested controls. Others were uncontrolled, making the results harder to interpret confidently.
• The difficulty of capturing acute infections: Because the initial illness is often so mild that patients don't seek medical attention, researchers almost always miss the window for isolating the virus or demonstrating rising antibody titres. This is why most serological evidence is of static (unchanging) antibody levels, which is weaker evidence of causation.
• Unreliable laboratory testing: The CDC study showed that the same serum sample tested repeatedly could show fourfold differences in titres on nearly 18 percent of occasions. This means that single blood tests for viral antibodies are inherently unreliable for diagnosing persisting infections.
• Limited availability of advanced testing: Sophisticated tests like ³¹P NMR spectroscopy and single-fiber EMG were only available to a minority of patients at specialist centers. The muscle biopsy findings, while compelling, were not available for all patients, and not all patients would willingly undergo the procedure.
• The non-specific nature of many findings: The muscle "jitter" abnormalities on single-fiber EMG, for example, had also been found in patients with acute viral infections generally, making them non-specific rather than diagnostic.
• The aetiology question remains open: The author explicitly states that the question of aetiology "must remain open for the time being" — no single causative agent was identified.
• Historical context: This review was published in 1988. While it provides an excellent historical foundation, molecular virology and immunology have advanced enormously since then, and patients should interpret these findings in light of more recent research.

Recommendations for Patients

Based on the findings and caveats in this review, here are practical recommendations for patients experiencing prolonged fatigue after an infection:

1. Seek proper medical evaluation. Persistent fatigue deserves a thorough medical workup to rule out other causes and to document your symptoms. The fact that physical signs are often subtle does not mean nothing is wrong.
2. Be patient with recovery. Historical data show that recovery can take months to years. It is normal to have a slow, fluctuating course. The fact that immune parameters returned to normal in patients who recovered suggests that improvement is biologically possible.
3. Expect that a single blood test may not give clear answers. As the CDC study demonstrated, viral antibody tests can be unreliable on single samples. Be cautious about diagnoses based on one test alone, whether positive or negative.
4. Understand that more than one virus may be involved. You may have been tested for EBV and Coxsackie B and found negative — but other viruses like cytomegalovirus, hepatitis A, or influenza could also trigger the syndrome. A negative test for one virus does not exclude the diagnosis.
5. Recognize the physical basis of your symptoms. The evidence presented in this review — muscle fiber abnormalities, metabolic defects, and immune imbalances — validates that your fatigue, muscle weakness, and cognitive difficulties have a biological foundation.
6. Pace your physical activity. Since weakness is described as following muscular effort and persisting for hours or days afterward, pacing activities to avoid prolonged post-exertional crashes may help you manage daily life while your body recovers.
7. Seek support. The existence of patient support groups like the ME Association, which had thousands of members and generated enormous volumes of enquiries (11,000 from one article alone), demonstrates that you are not alone. Connecting with others who share your experience can be validating and supportive.
8. Keep an open dialogue with your doctor. Because this condition has been historically controversial, you may encounter doctors who are skeptical. The scientific evidence reviewed here can help you advocate for a thoughtful, evidence-based discussion about your symptoms.

Frequently Asked Questions

What is post-infectious disease syndrome?

It is a condition that can start after an infection. Its three core features are fatigue, muscle weakness, and variable neurological symptoms. Many patients trace the beginning to a mild viral-type illness. Symptoms may include mental exhaustion, poor concentration, tingling, blurred vision, headaches, and mood swings. Muscle weakness often follows effort and lasts for hours or days.

Is this condition real or psychological?

Although some doctors once called it mass hysteria, evidence shows it has a real physical basis. Muscle biopsies, single-fiber EMG tests, and immune studies often reveal objective abnormalities. The review concludes that many, if not most, patients have demonstrable abnormalities of muscle physiology using very discriminating tests. The symptoms are not simply 'all in the head.'

Which infections are linked to this syndrome?

No single virus causes it. Coxsackie B enteroviruses and Epstein-Barr virus have serological links, but hepatitis A, cytomegalovirus, chickenpox, influenza, and measles may also trigger it. Because multiple agents can be involved, a negative test for one virus does not exclude the diagnosis.

How long does recovery take?

Recovery times vary greatly. In one outbreak, over half of affected staff took six months or more to return to full duties. In another, over 10 percent remained unwell after three years. In Iceland, only 44 percent of severely affected patients fully recovered after seven years. However, many patients do recover, and immune parameters can return to normal.

Are blood tests reliable for diagnosing this condition?

A single blood test may not give clear answers. A CDC investigation found that repeating the same serum sample produced fourfold differences in antibody titres on nearly 18 percent of occasions. Viral antibody tests can be unreliable on one sample. Doctors often miss the window to detect rising antibody levels because the initial illness is mild.

What should I do if I have these symptoms?

Seek a thorough medical evaluation to rule out other causes. Be patient, since recovery can be slow and fluctuating. Pace your physical activity because weakness can follow effort and persist. Understand that one blood test may not be definitive. Seek support from patient groups and keep an open dialogue with your doctor about the evidence.

What physical abnormalities are found in patients?

Muscle biopsy in one study showed excess type II muscle fibers and cell death in 15 of 20 patients. Single-fiber EMG found abnormal jitter in 30 of 40 patients. Some patients had elevated myoglobin, impaired oxidative metabolism, and abnormal immune cell ratios. These findings suggest a true biological basis for muscular fatigue.

Source Information

Original article title: Postinfectious disease syndrome

Journal: Postgraduate Medical Journal (1988), Volume 64, pages 559–567

Publication details: © The Fellowship of Postgraduate Medicine, 1988. First published as 10.1136/pgmj.64.753.559 on 1 July 1988.

Note: This patient-friendly article is based on peer-reviewed research. It is intended for educational purposes and does not constitute medical advice. Patients experiencing chronic fatigue should consult a qualified healthcare professional for proper diagnosis and management. This 1988 review provides a historical foundation; readers seeking current information on post-infectious fatigue syndromes (including myalgic encephalomyelitis/chronic fatigue syndrome, ME/CFS) should consult recent medical literature, as scientific understanding has advanced considerably since this article was published.